Iris involvement by lymphoma: a review of 13 cases

Clin Exp Ophthalmol. 2013 Jan-Feb;41(1):19-26. doi: 10.1111/j.1442-9071.2012.02811.x. Epub 2013 Jan 9.

Abstract

Background: To describe the clinical and histopathological features of lymphomas involving the iris.

Design: Retrospective, descriptive study.

Participants: Fourteen eyes of 13 patients.

Methods: Review of medical records.

Main outcome measures: Clinical and histopathological findings.

Results: Median patient age was 58 years (range, 25-76 years). Seven patients had known systemic lymphoma of which five were of large B-cell type. Symptoms included blurred vision (8/14), eye redness (3/14) and eye pain (2/14). Four eyes had secondary elevated intraocular pressure. Anterior segment findings included anterior chamber cells (14/14 eyes), keratic precipitates (11/14 eyes), congestion of conjunctival/episcleral blood vessels (9/14), hyphaema (7/14), conjunctival/anterior epibulbar lymphoma (6/14), tumour-induced pseudohypopyon (4/14) and corneal oedema (3/14). Of 12 eyes with adequate view of iris details, clinically detectable iris thickening or visible mass was noted in all (12/12). There was concomitant involvement of ciliary body (8/14), choroid (5/14) and orbit (2/14). All patients had biopsy of conjunctiva, episclera, iris or ciliary body, confirming the diagnosis of lymphoma. Histopathological or cytopathological evaluation of iris or ciliary body showed high-grade lymphoma in 9/11 eyes in which it was performed. Five patients did not have long-term follow up and, of the other eight patients, three died from complications of systemic lymphoma during follow up ranging from 1 to 44 months.

Conclusion: Lymphomatous involvement of the iris should be considered in the differential diagnosis of corticosteroid-resistant uveitis in middle-aged and elderly patients. Iris lymphoma tends to be high grade and usually develops in patients with known aggressive systemic lymphoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Biopsy
  • Combined Modality Therapy
  • Female
  • Humans
  • Intraocular Pressure / physiology
  • Iris Neoplasms / diagnostic imaging
  • Iris Neoplasms / pathology*
  • Iris Neoplasms / therapy
  • Lymphoma, B-Cell / diagnostic imaging
  • Lymphoma, B-Cell / pathology*
  • Lymphoma, B-Cell / therapy
  • Male
  • Microscopy, Acoustic
  • Middle Aged
  • Ophthalmologic Surgical Procedures
  • Radiotherapy
  • Retrospective Studies
  • Visual Acuity / physiology

Substances

  • Antineoplastic Agents